Cizzle Bio, Inc. is at the forefront of biotechnological innovation, dedicated to revolutionizing lung cancer detection through our pioneering CIZ1B biomarker blood test. Our mission is to improve early-stage lung cancer diagnosis, enhancing patient outcomes with non-invasive, highly accurate diagnostic solutions. In collaboration with Cizzle Biotechnology PLC, we utilize patented technologies to offer an effective alternative to traditional screening methods. With a focus on continuous innovation, strategic partnerships, and patient-centered care, we aim to make early cancer detection accessible and reliable for all.

Cizzle Bio, Inc.

Org chart

Teams

Offices